Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Plasma 25-hydroxyvitamin D and prostate cancer risk: the multiethnic cohort.

Park SY, Cooney RV, Wilkens LR, Murphy SP, Henderson BE, Kolonel LN.

Eur J Cancer. 2010 Mar;46(5):932-6. doi: 10.1016/j.ejca.2009.12.030. Epub 2010 Feb 8.

2.

Serum zinc and prostate cancer risk in a nested case-control study: The multiethnic cohort.

Park SY, Wilkens LR, Morris JS, Henderson BE, Kolonel LN.

Prostate. 2013 Feb 15;73(3):261-6. doi: 10.1002/pros.22565. Epub 2012 Jul 31.

3.

Serum vitamin D concentration and prostate cancer risk: a nested case-control study.

Ahn J, Peters U, Albanes D, Purdue MP, Abnet CC, Chatterjee N, Horst RL, Hollis BW, Huang WY, Shikany JM, Hayes RB; Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Project Team.

J Natl Cancer Inst. 2008 Jun 4;100(11):796-804. doi: 10.1093/jnci/djn152. Epub 2008 May 27.

4.

Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort study.

Kim Y, Franke AA, Shvetsov YB, Wilkens LR, Cooney RV, Lurie G, Maskarinec G, Hernandez BY, Le Marchand L, Henderson BE, Kolonel LN, Goodman MT.

BMC Cancer. 2014 Jan 17;14:29. doi: 10.1186/1471-2407-14-29.

5.

Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men.

Layne TM, Weinstein SJ, Graubard BI, Ma X, Mayne ST, Albanes D.

Cancer. 2017 Jul 15;123(14):2698-2704. doi: 10.1002/cncr.30634. Epub 2017 Apr 3.

PMID:
28369777
6.

Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.

Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E.

Cancer Causes Control. 2004 Apr;15(3):255-65.

PMID:
15090720
7.

Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations.

Haiman CA, Stram DO, Vickers AJ, Wilkens LR, Braun K, Valtonen-André C, Peltola M, Pettersson K, Waters KM, Marchand LL, Kolonel LN, Henderson BE, Lilja H.

J Natl Cancer Inst. 2013 Feb 6;105(3):237-43. doi: 10.1093/jnci/djs486. Epub 2012 Dec 3.

8.

Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study.

Woolcott CG, Wilkens LR, Nomura AM, Horst RL, Goodman MT, Murphy SP, Henderson BE, Kolonel LN, Le Marchand L.

Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):130-4. doi: 10.1158/1055-9965.EPI-09-0475.

9.

Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States)

Nomura AM, Stemmermann GN, Lee J, Kolonel LN, Chen TC, Turner A, Holick MF.

Cancer Causes Control. 1998 Aug;9(4):425-32.

PMID:
9794175
10.

Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).

Travis RC, Crowe FL, Allen NE, Appleby PN, Roddam AW, Tjønneland A, Olsen A, Linseisen J, Kaaks R, Boeing H, Kröger J, Trichopoulou A, Dilis V, Trichopoulos D, Vineis P, Palli D, Tumino R, Sieri S, Bueno-de-Mesquita HB, van Duijnhoven FJ, Chirlaque MD, Barricarte A, Larrañaga N, González CA, Argüelles MV, Sánchez MJ, Stattin P, Hallmans G, Khaw KT, Bingham S, Rinaldi S, Slimani N, Jenab M, Riboli E, Key TJ.

Am J Epidemiol. 2009 May 15;169(10):1223-32. doi: 10.1093/aje/kwp022. Epub 2009 Apr 9.

11.

A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.

Deschasaux M, Souberbielle JC, Latino-Martel P, Sutton A, Charnaux N, Druesne-Pecollo N, Galan P, Hercberg S, Le Clerc S, Kesse-Guyot E, Ezzedine K, Touvier M.

Br J Nutr. 2016 Jan 28;115(2):305-14. doi: 10.1017/S0007114515004353. Epub 2015 Nov 16.

PMID:
26568368
12.

Plasma 25-hydroxy vitamin D and subsequent prostate cancer risk in a nested Case-Control study in Japan: The JPHC study.

Sawada N, Inoue M, Iwasaki M, Yamaji T, Shimazu T, Sasazuki S, Tsugane S.

Eur J Clin Nutr. 2017 Jan;71(1):132-136. doi: 10.1038/ejcn.2016.184. Epub 2016 Oct 19.

PMID:
27759068
13.

Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.

Shui IM, Mucci LA, Kraft P, Tamimi RM, Lindstrom S, Penney KL, Nimptsch K, Hollis BW, Dupre N, Platz EA, Stampfer MJ, Giovannucci E.

J Natl Cancer Inst. 2012 May 2;104(9):690-9. doi: 10.1093/jnci/djs189. Epub 2012 Apr 12.

14.

A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.

Li H, Stampfer MJ, Hollis JB, Mucci LA, Gaziano JM, Hunter D, Giovannucci EL, Ma J.

PLoS Med. 2007 Mar;4(3):e103.

15.

Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP.

Steck SE, Arab L, Zhang H, Bensen JT, Fontham ET, Johnson CS, Mohler JL, Smith GJ, Su JL, Trump DL, Woloszynska-Read A.

PLoS One. 2015 Apr 28;10(4):e0125151. doi: 10.1371/journal.pone.0125151. eCollection 2015.

16.

Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.

Gilbert R, Metcalfe C, Fraser WD, Donovan J, Hamdy F, Neal DE, Lane JA, Martin RM.

Int J Cancer. 2012 Sep 1;131(5):1187-96. doi: 10.1002/ijc.27327. Epub 2011 Dec 21.

17.

Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer.

Weinstein SJ, Mondul AM, Kopp W, Rager H, Virtamo J, Albanes D.

Int J Cancer. 2013 Jun 15;132(12):2940-7. doi: 10.1002/ijc.27969. Epub 2012 Dec 27.

18.

Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study.

Weinstein SJ, Yu K, Horst RL, Parisi D, Virtamo J, Albanes D.

PLoS One. 2011;6(6):e20796. doi: 10.1371/journal.pone.0020796. Epub 2011 Jun 10.

19.

Urinary phytoestrogen excretion and prostate cancer risk: a nested case-control study in the Multiethnic Cohort.

Park SY, Wilkens LR, Franke AA, Le Marchand L, Kakazu KK, Goodman MT, Murphy SP, Henderson BE, Kolonel LN.

Br J Cancer. 2009 Jul 7;101(1):185-91. doi: 10.1038/sj.bjc.6605137. Epub 2009 Jun 16.

20.

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.

Albanes D, Mondul AM, Yu K, Parisi D, Horst RL, Virtamo J, Weinstein SJ.

Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1850-60. doi: 10.1158/1055-9965.EPI-11-0403. Epub 2011 Jul 22.

Supplemental Content

Support Center